Results 241 to 250 of about 2,804,815 (317)

Cyclic azapeptide CD36 ligand attenuates cardiac injury and reduces long‐chain fatty acid accumulation after myocardial ischemia–reperfusion in mice

FEBS Open Bio, EarlyView.
In a murine model of myocardial ischemia and reperfusion (MI/R), the CD36 azapeptide ligand MPE‐298 reduces cardiac injury and transiently lowers left ventricular long‐chain fatty acids (LCFAs) accumulation 3 h after reperfusion, accompanied by a decrease of oxidative stress and inflammation‐associated genes' expression in the heart and adipose tissue.
Jade Gauvin, Naghme Radmannia, David N. Huynh, Liliane Ménard, Caroline Daneault, Maïté Veilleux, Ahsanullah Ahsanullah, André C. Carpentier, William D. Lubell, Matthieu Ruiz, Huy Ong, Sylvie Marleau, Simon‐Pierre Gravel   +12 more
wiley   +1 more source

Trend, application, and reporting of Mini-health technology assessment: an evidence mapping. [PDF]

Int J Technol Assess Health Care
Wang Z, Li Y, Xu M, Liu W, Yan Y, Wang Y, Wu Y, Li M, Li X, Zhang X.   +9 more
europepmc   +1 more source

Political analysis of health technology assessment implementation in Iran. [PDF]

Health Res Policy Syst
Behzadifar M, Azari S, Bakhtiari A, Shahabi S, Martini M, Yarahmadi M, Behzadifar M.   +6 more
europepmc   +1 more source